19 Jul 2022 Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR Member news
13 Jul 2022 Agomab raises additional $40.5 million through Series B extension bringing total amount to $114 million Member news
05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
28 Jun 2022 MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis Member news
28 Jun 2022 Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases Member news
24 Jun 2022 argenx receives positive CHMP opinion for efgartigimod for the treatment of adult patients with generalized myasthenia gravis in Europe Member news
24 Jun 2022 ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company Member news
23 Jun 2022 Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry Member news
23 Jun 2022 Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
